Abbreviations: a 1 m, a 1 -microglobulin; LIPR, leucine-isoleucine-proline-arginine; t-a 1 m, truncated a 1 -microglobulin ( ¼ lacking the C-terminal tetrapeptide LIPR).
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Several causative mechanisms underlying the chronic in£ammation have been proposed. The sustained venous pressure of these patients leads to a reduced pressure di¡erential between the arterial and venous systems, thus trapping leukocytes in the connective tissue. Extravasation of leukocytes also occurs in nonulcer patients with venous disease and may lead to ulcer formation (Wilkinson et al, 1993) . Extravasation of ¢brin lead to the formation of ¢brin depositions (¢brin cu¡s), possibly trapping and inactivating growth factors involved in wound healing in the perivascular areas (Falanga, 2001) . Furthermore, all chronic ulcers are constantly colonized or infected by various bacteria such as Pseudomonas aeruginosa, Escherichia faecalis, and P. mirabilis and recent evidence supports the view that high bacterial loads contribute to nonhealing (Davies et al, 2001) .
Iron, in free form or complex-bound to protoporphyrin IX in heme, has been implicated as an important pathogenic factor in in£ammation in general and in leg ulcers in particular (Ackerman et al, 1988; Wagener et al, 2001; Wenk et al, 2001) . The oxidized ferric (Fe 3 þ ) forms of heme and free iron are strong oxidative agents and the ferrous iron (Fe 2 þ ) can generate oxygen-derived free radicals by the Fenton reaction (Halliwell and Gutteridge, 1989) . These compounds present considerable oxidative stress that leads to tissue damage and cell destruction, and have been proposed to participate in the pathogenesis of chronic ulcers (for a review, see -gren et al, 2000) by initiating local lipid peroxidation of polyunsaturated fatty acids in cell membranes as well as enhancing the synthesis and activation of matrix-degrading metalloproteinases.
a 1 -Microglobulin (a 1 m) is a 26 kDa glycoprotein that is evolutionarily well-conserved and has so far been found in mammals, birds, ¢sh, and amphibians (-kerstr˛m and L˛gdberg, 1990; -kerstr˛m et al, 2000b) . It belongs to the lipocalin superfamily, a group of proteins from animals, plants, and bacteria with very diverse functions but a well-conserved three-dimensional structure (-kerstr˛m et al, 2000a) . The lipocalins consist of a 160 to 190 amino acid polypeptide folded into an eight-stranded b-barrel surrounding a pocket that can bind hydrophobic ligands. About half of the a 1 m-molecules are complex-bound to IgA (Grubb et al, 1986) . Both free and IgA-bound a 1 m are found in most tissues intravascularly and extravascularly. It was recently shown that a 1 m has heme-binding properties and may be involved in extracellular heme catabolism (Allhorn et al, 2002) . Formation of a processed form of a 1 m, lacking the C-terminal tetrapeptide LIPR (leucine-isoleucine-proline-arginine), is induced by hemoglobin. This processed a 1 m form, called t-a 1 m (t ¼ truncated), has both heme-binding and heme-degrading properties. The results indicate a protective role of a 1 m against heme-induced oxidative damage. Considering the proposed pathogenic role of heme, we have investigated concentration, distribution, and biochemical properties of a 1 m in wound £uids from chronic venous leg ulcers. It is shown that a 1 m is ubiquitously distributed in wound sections, that it is a heme-binding protein in ulcer £uids, and that t-a 1 m is formed. These results are consistent with a protective role of a 1 m in the ulcer £uids as a heme antagonist.
MATERIALS AND METHODS
Patients, wound £uid, and plasma Wound £uid and plasma were collected from patients with venous ulcers. Wound £uid was collected either by sampling on ¢lters as described previously (Schmidtchen, 1999 (Schmidtchen, , 2000 or under a Tegaderm dressing (Schmidtchen, 2000) . In the ¢rst procedure (used in experiments described in Fig 1; sampling from a group of 12 patients), sterilized ¢lters (Whatman GF/D; diameter 2.5 cm) were applied to wounds for 4 h and wound £uid was extracted from the ¢lter. Proteinase activity was blocked by the addition of the proteinase inhibitors diisopropyl phosphoro£uoridate, N-ethylmaleimide, and ethylenediamine tetraacetic acid (Schmidtchen, 2000) . The ¢lters did not induce degradation of a 1 -m in human plasma (not shown). Wound £uid from 12 patients with venous ulcers (43 mo duration) was used for the experiments. In the second procedure (used for all other experiments), Tegaderm dressings were applied on the wound and wound £uid was collected by gentle aspiration underneath the ¢lm after 2 h, centrifuged at 10,000 r.p.m. (3500 g) in an Eppendorf centrifuge, aliquoted and stored at^201C until further use. The venous insu⁄ciency was routinely determined either by a handheld Doppler (5 MHz probe; examination of re£ux in the politeal vein, great saphenous vein and small saphenous vein) or by color duplex examination. The patients had a systolic index of more than 0.8. Patients with diabetes or signs of general infection (malaise, fever) or local infection (cellulitis, erysipelas) were excluded. Plasma from healthy volunteers was collected by intravenous puncture. The research project was approved by the local Ethics Committee. Informed consent was obtained from the patients.
Proteins and reagents Human plasma a 1 m was prepared from plasma as described previously (-kerstr˛m et al, 1995; BerggÔrd et al, 1997 BerggÔrd et al, , 1999 . Protein LG was a generous gift from Dr Lars Bj˛rck, Department of Cell and Molecular Biology, Lund University, Sweden, and was coupled to CNBr-activated Sepharose-4B (Pharmacia-Biotech, Uppsala, Sweden), 7 mg per mL gel, as described by Pharmacia-Biotech. Orosomucoid, human albumin and other chemicals were from Sigma-Aldrich Stockholm, Sweden AB if not indicated otherwise. Mouse monoclonal anti-human a 1 m antibody was raised as described (Nilson et al, 1987) . Rabbit anti-serum against human a 1 m was prepared in this laboratory by following the earlier description (BerggÔrd and Bearn, 1968) . Rabbit anti-LIPR was prepared by AgriSera AB (VÌnnÌs, Sweden) by immunization with the synthetic peptide CKKLIPR conjugated to keyhole limpet hemocyanin (KLH). The preparation of goat anti-rabbit immunoglobulins has been described previously (Bj˛rck et al, 1977) . Proteins were labeled with [ 125 I]iodide (Bio-Nuclear AB, Stockholm, Sweden) using the chloramine T method (Greenwood et al, 1963) . Labeled proteins were separated from free iodide by gel ¢ltration on Sephadex G-25 column (Pharmacia). The speci¢c activity was approximately 0.5 MBq per mg protein.
Sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) and immunoblotting of a 1 m in wound £uids and plasma The molecular forms of a 1 m in wound £uids and plasma were investigated by SDS^PAGE and immunoblotting. SDS^PAGE was performed under denaturing conditions using 12% gels in the bu¡er system described by Laemmli (1970) . Samples mixed with sample bu¡er 1:1 (v/v) containing 2% (v/v) b-mercaptoethanol and SDS were boiled 3 min before loading to the gel. High molecular mass standards (Rainbow markers, Amersham, International plc, Amersham, Buckinghamshire, England) were used. The gels were stained with Coomassie Brilliant Blue R-250 (BDH Chemicals, Ltd, Poole, UK) and dried. In some cases 3% to 12% polyacrylamide gradient gels with a 3% stacking gel were used. The separated proteins were transferred to polyvinylidene £uoride membranes (Immobilon, Millipore, Bedford, Massachusetts) as described (Matsudaira, 1987) . Immunoblotting was performed as previously described (Schmidtchen, 1999) using polyclonal anti-sera against a 1 m diluted 1000 times. The membranes were developed using the ECL system (Boehringer, Mannheim GmbH, Mannheim, Germany).
A⁄nity chromatography of wound £uids To distinguish between full-length a 1 m and t-a 1 m, i.e., the form of the protein that lacks the Cterminal tetrapeptide LIPR, a 1 m was puri¢ed from wound £uids by antia 1 m a⁄nity chromatography and subsequently immunoblotted both with antibodies against full-length a 1 m and antibodies against LIPR. A⁄nity chromatography was performed according to an earlier description (Allhorn et al, 2002) , using mouse monoclonal anti-a 1 m, BN11.10, which had been immobilized to A⁄gel Hz (Bio-Rad Laboratories, Hercules, California) at 20 mg per mL following instructions from the merchant. The eluted proteins were separated by SDS^PAGE and identi¢ed by immunoblotting (see above) using anti-a 1 m diluted 1000 times or anti-LIPR diluted 300 times. The blots were developed by incubation with 125 I-goat anti-rabbit immunoglobulin as described (Wester et al, 1997) and analysis with a Fuji Bas 2000 Bio-imaging analyzer (Fuji Films Co., Japan).
Cleavage of a 1 m by wound £uids The cleaving activity of wound £uids was tested by adding small amounts of radiolabeled a 1 m. One Bq of 125 I-a 1 m or 125 I-IgA-a 1 m was added to 1 mL wound £uid (10 mg total proteins as measured by the Bradford method) diluted in phosphate-bu¡ered saline (PBS: 10 mM phosphate bu¡er, pH 7.4, 120 mM NaCl, 3 mM KCl). The reaction proceeded for 1 h at room temperature. The samples were then applied to SDS^PAGE and the dried gel analyzed with a Fuji Bas 2000 Bio-imaging analyzer.
Binding of [ 14 C]heme to a 1 m in wound £uids [ 14 C]heme was produced using the Escherichia coli strain AN344 containing the plasmid pTYR13 as described by Schi˛tt et al, 1997) . AN344 is blocked in deltaamino levulnic acid (ALA) synthesis and requires ALA for growth. Thus, the addition of 31 mM (50.8 Ci per mol) [4 -14 C]ALA (New England Nuclear Inc., Boston, MA) to strain AN344/pTYR13 in Luria broth (LB) medium resulted in production of [ 14 C]heme with the yield 20 nmol per 60 mL culture and with a speci¢c activity of 2.5 Ci per mmol. [ 14 C]heme (15 pmol) was incubated with 1.5 mL wound £uid (15 mg total proteins as measured by the Bradford method) with or without added a 1 m (45 pmol) or albumin (45 pmol), or incubated with these amounts of a 1 m or albumin alone, diluted in PBS þ 0.05% Tween-20 to 10 mL. After 30 min at 201C, SDS^PAGE sample bu¡er was added and the samples analyzed by SDSP AGE as described above, the gels dried and the radioactivity analyzed with a Fuji Bas 2000 Bio-imaging analyzer. Binding of [ 14 C]heme in HepG2 cell cultures To measure the binding of heme to newly synthesized a 1 m, [ 14 C]heme was added to cultures of the liver cell line HepG2, which synthesize and secrete a 1 m. HepG2 cells were grown at 371C in RPMI 1640 medium (Gibco, Life Technologies, Gaithersburg, MD) in an atmosphere of 5%. The medium contained 10% fetal bovine serum (FBS), L-glutamine, 300 mg per mL, and 100 mg per mL antibiotics (penicillin and streptomycin). In one experiment, 0.03 mM Na 2 SeO 3 was used instead of FBS, using conditions described previously (-kerstr˛m et al, 1995) . The cells were split 1:5 or 1:10 by trypsin digestion twice a week. Fresh culture medium was added to £asks with con£uent cells, and 24 h later, [ 14 C]heme was added to a ¢nal concentration of 0.07 to 0.4 mM and the incubation proceeded for 3 h. The cells were centrifuged and the medium removed and saved for immunoprecipitation, puri¢cation of a 1 m by a⁄nity chromatography (see above), and radioimmunoassay. The cells were lyzed by resuspension in 15 mL 20 mM Tris^HCl, pH 8.0, 150 mM NaCl, 0,02% NaN 3, 1% Triton X-100, 0.25% nonidet P-40, 0.25% bovine serum albumin. The suspension was then centrifuged, 1000 r.p.m., (700g) 20 min 1 mL medium or 1 mL cell lysate was immunoprecipitated with 10 mL of polyclonal antibody (100 mg IgG) against a 1 m. As a control, 10 mL polyclonal antiorosomucoid (Dakopatts Glostrup, Denmark) was used. After 20 h incubation at 41C, 30 mL protein LG-Sepharose (50% 1:1 suspension) was added and the incubation continued for 2 h at room temperature. After centrifugation and removal of supernatant, the immunoprecipitates were washed several times with PBS. The pellets were ¢nally solubilized in SDS^PAGE sample bu¡er and analyzed by SDS^PAGE. The gels were dried and analyzed with a Fuji Bas 2000 Bio-imaging analyzer.
Biopsies Four millimeter biopsies were taken from the wound edge of a chronic venous leg ulcer. Control biopsies were taken from the edges of acute wounds or from healthy skin of the thigh. The tissue samples were ¢xed overnight in 4% paraformaldehyde, dehydrated sequentially in ethanol and subsequently embedded in para⁄n. Tissue sections (5 mm) were cut in a microtome, mounted on slides, and air dried overnight in a 371C incubator.
Immunohistochemistry Sections were depara⁄nized by routine procedures and endogenous peroxidase activity was blocked with 3% H 2 O 2 in methanol for 10 min. After rinsing in distilled water, followed by PBS, the slides were subsequently permeabilized with Tween 20 (0.05%) in PBS. Thereafter, sections were rinsed in PBS. After preincubation with normal goat serum (1%) for 30 min at room temperature, incubation was performed with primary antibody diluted 1:500 in PBS (containing 0.05% Tween 20, 0.2% bovine serum albumin) overnight at 41C. Control sections were incubated in the same PBS solution without antibody. Antibody detection was performed with a standard avidin^biotin complex detection system after which they were developed with 3,3 0 ,-diaminobenzidine tetrahydrochloride as the chromogenic substrate (Vectastain avidin^biotin complex, Vector Laboratories, Burlingame, California). Sections were counterstained with Mayer's Hemalum (Diagnostica Merc, Darmstadt, Germany), mounted with Pertex (Histolab Products AB, Gothenburg, Sweden) and examined and photographed (Olympus BHS photomicrographic system).
Iron and porphyrin staining For iron staining, para⁄n-embedded skin sections were dewaxed and rehydrated. Iron deposition was examined using Perls' Prussian blue staining. The sections were incubated in a solution containing 1% potassium ferrocyanide in 1% HCl for 1 h. After several washes in H 2 O the sections were incubated with a 1% neutral red solution for 5 min and washed again in H 2 O. Dehydrated and di¡erentiated sections were mounted in DPX-type mountant. Porphyrins were stained using Fouchet technique, the method of choice for demonstration of bile pigments. After 5 min incubation in a reagent containing 12.5% trichloroacetic acid and 5% aqueous ferric chloride, the sections were washed in distilled water and counterstained with van Gieson's solution: saturated picric acid, 0.1% acid fuchsin, and 0.1% glacial acetic acid, for 3 min. The sections were washed in alcohol before dehydration.
Determination of a 1 m, porphyrin, and iron concentrations in wound £uids and plasma Speci¢c concentrations of a 1 m were measured by a soluble competitive radioimmunoassay (-kerstr˛m, 1985) . Protoporphyrin IX was detected using the pyridin-hemochromogen method as described by Falk (1964) . Iron concentrations were determined by a spectrophotometric procedure with hydroxylamine and thioglycolate as the reducing agents and ferrozine as the ferrous ion complexing agent, at the Department of Clinical Chemistry, Malm˛General Hospital, Malm˛, Sweden. The assays were performed with SYNCHRON LX Systems, Beckman Coulter, Inc., Fullerton California.
RESULTS
a 1 m in wound £uids The wound £uids from 12 patients with chronic venous ulcers contained three variants of a 1 m: free monomeric a 1 m, t-a 1 m, and a 1 m complex-bound to IgA (IgAa 1 m) when analyzing by SDS^PAGE (Fig 1) . The IgA-a 1 m complex appears on SDS^PAGE as a nonreducable 90 kDa protein band containing a 1 m covalently linked to the a-chain. A large variation in the relative concentrations of the three forms was noted. In contrast, plasma from the same patients contained no t-a 1 m and displayed less variation between individuals. Furthermore, the various high-molecular-weight a 1 m complexes described previously (BerggÔrd et al, 1997) could be seen in plasma samples but were absent in wound £uids. T-a 1 m in wound £uids was identi¢ed by puri¢cation of a 1 m on anti-human a 1 m a⁄nity chromatography, followed by immunoblotting with anti-LIPR (Fig 2) . The results obtained con¢rmed that the protein band corresponding to t-a 1 m on SDS^PAGE lacked the C-terminal tetrapeptide.
Cleavage of a 1 m The appearance of t-a 1 m on SDS^PAGE prompted a further investigation of the cleaving activity of wound £uids. Thus, 125 I-a 1 m or 125 I-IgA-a 1 m was added to wound £uid samples and the mixtures were then analyzed on SDS^PAGE. The results obtained revealed the presence of a radioactive protein band corresponding to t-a 1 m, approximately 3 to 4 kDa smaller compared with native a 1 m (Fig 3) . 125 I-IgAa 1 m was also processed, which caused disappearance of the 90 kDa band and appearance of free a 1 m.
Binding of [ 14 C]heme to a 1 m a 1 m was added to wound £uid and the binding to exogenously added [ 14 C]heme was tested (Fig 4) . A clear binding of radiolabeled heme to a 1 m in the wound £uids could be seen (lane 1) and to a 1 m alone without wound £uid present (lane 2). Albumin, a known physiologic heme-binding protein, also bound the added heme when added to wound £uid (lane 3). The binding of [ 14 C]heme to wound £uid without previous addition of a 1 m or albumin was not detected (not shown), possibly due to low concentrations of the proteins and/or because endogenous a 1 m is saturated with pre-existing heme in the wound £uids.
Binding of [ 14 C]heme by a 1 m in HepG2 cells
To examine the heme-binding properties of newly synthesized a 1 m not Figure 2 . a 1 m and t-a 1 m puri¢ed from wound £uids. a 1 m from 100 mL wound £uid, collected from each of three patients with chronic leg ulcers, were puri¢ed by a⁄nity chromatography on a column with immobilized monoclonal antibodies against a 1 m. The eluates (lanes 1^3) were electrophoresed on 10% SDS^PAGE under reducing conditions and immunoblotted with anti-a 1 m (A) and anti-LIPR (B). Lane 4 shows plasma a 1 m and lane 5 corresponds to t-a 1 m, obtained by incubation of plasma a 1 m with erythrocyte membranes as described (Allhorn et al, 2002 ).
previously exposed to heme, human hepatoblastoma (HepG2) cells were used. These cells synthesize a 1 m as a precursor protein, a 1 m/bikunin, which is cleaved intracellularly and the proteins are secreted separately. Thus, [ 14 C]heme was added to the culture medium containing newly synthesized and secreted a 1 m. This medium was then immunoprecipitated with polyclonal antisera. The results displayed in Fig 5(A) show that the [ 14 C]heme added to HepG2 cells bound to a 1 m, but not to orosomucoid also synthesized by the HepG2 cells. Medium was also applied to a monoclonal a⁄nity chromatography column and a 1 m isolated by a⁄nity chromatography could be seen as a radioactive band on SDS^PAGE ( Fig 5B) . The lyzed cells from the same cultivation did not show any radioactivity on SDSP AGE, suggesting that there were too small amounts of [ 14 C]heme bound intracellularly to be detected (not shown). To exclude the possibility that [ 14 C]heme bound to proteins from the FBS in the medium, FBS was replaced by Na 2 SeO 3 . In this case the binding of [ 14 C]heme to a 1 m was even more pronounced, as indicated in Fig 5(B) , possibly as a result of the absence of competing heme-binding factors in FBS. The synthesis rate of a 1 m was similar with or without FBS (not shown).
Iron, heme, and a 1 m in wound £uids and sections The skin sections from patients with chronic ulcers and from healthy individuals were investigated histologically using polyclonal anti-sera directed against a 1 m. The results revealed a global distribution of a 1 m in the dermis layer, with more intense staining in basement membranes and ¢brin cu¡s surrounding the blood vessels ( Fig 6B) . The normal skin section prepared from a healthy individual also displayed a ubiquitous distribution of a 1 m with increased amounts around vessels ( Fig 6A) . Porphyrin-speci¢c staining showed the presence of porphyrins in basement membranes and ¢brin cu¡s around vessels, i.e., a colocalization with a 1 m, as well as in in¢ltrating blood cells ( Fig 6C) . In contrast, much less porphyrins were found in sections from patients with acute wounds (Fig 6E) or normal skin sections. Furthermore, pronounced iron deposits were seen in chronic ulcers (Fig 6D) , as opposed to acute wounds or skin sections from healthy individuals, which were negative with respect to iron (not shown). These results suggest that tissue deposition of heme and iron is accentuated in chronic ulcers as compared with acute wounds and normal skin, whereas a 1 m is ubiquitously present both in normal skin and chronic ulcers.
Heme (protoporphyrin IX), free iron, and a 1 m concentrations were determined in wound £uids and plasma from patients with chronic ulcers ( Table I) . The heme content was estimated to 19.8 mM (SEM 6.7) in wound £uids and 13.4 mM (SEM 3.6) in plasma. The iron concentration was 6.5 mM (SEM 2.7) in wound £uids and 7.3 mM (1.5) in plasma. The a 1 m concentration was 1.7 mM (SEM 0.8) in wound £uids and 1.9 mM (SEM 1.5) in plasma. As a control, the heme, iron, and a 1 m concentrations were determined in plasma from normal donors. The heme and a 1 m concentrations were 12.1 mM (SEM 3.6) and 1.8 mM (SEM 0.3), respectively (Table I) , i.e., similar values as in plasma from patients with chronic ulcers. The iron concentration in normal plasma was 13.9 (SEM 0.7), which is higher than in plasma and ulcer £uids from patients with chronic wounds.
DISCUSSION
Recent results indicate that the lipocalin a 1 m is a heme scavenger, and that it participates in protection against toxic e¡ects of extracellularly exposed heme. Heme has been proposed as an inducer of in£ammation and constitutes one of several pathogenic factors in chronic leg ulcers. Chronic venous ulcers, characterized by accumulated heme, may therefore serve as a relevant model for investigation of physiologic interactions between a 1 m and heme. The results in this study show the simultaneous presence of heme, iron, and a 1 m in chronic wound £uids and a colocalization of a 1 m and heme in tissue sections to basement membranes and ¢brin cu¡s around vessels. Moreover, a 1 m binds heme in the wound £uids and is processed into the truncated form t-a 1 m, which has heme-degrading properties. The results obtained here thus support a view of a 1 m as a heme scavenger during in£ammation.
It was previously noted that the C-terminal processing of a 1 m is induced by puri¢ed hemoglobin or by membranes from ruptured erythrocytes (Allhorn et al, 2002) . It was speculated that an oxidized form of hemoglobin, which can be found deposited in erythrocyte membranes, may be responsible for the cleavage. The identity of the cleaving factor(s) in the leg ulcer £uids was not determined in this investigation; however, hemoglobin is usually found in this type of chronic leg ulcers (Blomgren et al, 2001) and this paper as well as others (Wenk et al, 2001) has shown the presence of heme and iron. It is therefore possible that the processing of a 1 m in chronic leg ulcers is induced by hemoglobin, hemoglobin variants, or free heme. We have previously shown that t-a 1 m is excreted in normal urine and that urinary t-a 1 m may be elevated in urine from hemolytic patients (Allhorn et al, 2002) . In analogy, an increased t-a 1 m formation in patients with chronic ulcers may be re£ected as an elevated urinary t-a 1 m concentration in these patients, and therefore, it is interesting to speculate that the urinary a 1 m/t-a 1 m ratio could be a useful parameter for evaluation of the clinical status of the ulcer patients.
About 50% of a 1 m in blood is complex bound to monomeric IgA (Grubb et al, 1986; BerggÔrd et al, 1997) . The IgA-a 1 m complex is also found in extravascular compartments (BerggÔrd et al, 1999; Bouic et al, 1985; Vincent and Revillard, 1987) . It was shown that IgA-a 1 m is processed by erythrocyte membranes and hemoglobin, forming intact IgA and t-a 1 m (Allhorn et al, 2002) . IgA-a 1 m may therefore be regarded as a depot from which the activated t-a 1 m is released. Leg ulcer £uids cleaved exogenously added IgA-a 1 m, suggesting that a mobilization of activated, heme-binding and heme-degrading a 1 m from the IgA-a 1 m depot takes place in leg ulcers in vivo. IgA is a normal component of skin, and granular deposits containing various forms of IgA were found in skin from patients with dermatitis herpetiformis (Egelrud and BÌck, 1985) , suggesting a role of this molecule in homeostasis and pathology of the skin. It should therefore be of interest to investigate the normal distribution of IgA-a 1 m as well as the presence of the complex in the pathologic granular deposits. Other high-molecular-weight plasma forms with masses around 200 kDa, representing complexes with albumin, prothrombin, and other as yet unknown molecules, have also been found to be associated with a 1 m (BerggÔrd et al, 1997) . Interestingly, these high-molecular-weight complexes are still present in plasma from patients with chronic leg ulcers but absent in wound £uids, as judged by SDS^PAGE. The reason for this is unclear but demonstrates that the distribution and metabolism of the a 1 m complexes are di¡erent.
The liver is the main site of synthesis of a 1 m and only traces of a 1 m-encoding mRNA are found in other organs (Kaumeyer et al, 1986; Itoh et al, 1996; Daveau et al, 1998) . No production of a 1 m in keratinocytes or ¢broblasts could be detected (not shown). The a 1 m and a 1 m complexes found in ulcer £uids therefore most likely originate from the liver and are transported there via the blood, rather than being synthesized locally. Plasma a 1 m and hepatocyte-derived a 1 m could indeed bind to radiolabeled heme in wound £uids, supporting this view (Figs 4 and 5) . Such a transport of a 1 m from blood to tissues was demonstrated experimentally after injection of 125 I-labeled a 1 m and a 1 m complexes intravenously into rats (Larsson et al, 2000) . The protein composition in chronic wound £uids closely resembles that of plasma (Schmidtchen, 2000) , suggesting a leakage of plasma proteins into wounds and further supporting the notion that a 1 m in wound £uids is indeed plasma derived.
Heme was found both in ulcer £uids and in plasma of ulcer patients (Table I) . Heme was also found widely distributed in tissue sections from the chronic ulcers as opposed to acute wound sections or normal skin sections (Fig 6) . Owing to venous hypertension in chronic ulcers (-gren et al, 2000; Falanga, 2001 ), a £ow of heme from plasma to the extravascular compartments across the endothelium and basement membranes is expected. Heme may therefore be trapped and accumulated in the membranous compartments of the endothelium and basement membranes and accumulated in pericapillary ¢brin cu¡s, which probably develop as a result of venous hypertension and extravasation of ¢brinogen (Van de Scheur and Falanga, 1997) . Such a distribution of heme to basement membranes and ¢brin cu¡s was indeed found in this investigation. Interestingly, especially high amounts of a 1 m were also found in these compartments (Fig 6) , supporting the view of a 1 m as a heme scavenger. This localization of a 1 m also agrees with previous immunohistochemical studies of skin and placenta (Bouic et al, 1985; BerggÔrd et al, 1999) .
Free heme, released from hemoglobin and other heme proteins as a result of oxidation, generates reactive oxygen species leading to subsequent cell and tissue damage. Excess accumulation of heme causes an increased vasopermeability, increased expression of endothelial adhesion molecules and in¢ltration of leukocytes, signs of in£ammation (Wagener et al, 2001) . These events appear to be linked to the chronic in£ammation in venous leg ulcers. The pro-in£ammatory e¡ects of heme induce expression of heme oxygenase, an intracellular, heme-degrading enzyme (Panchenko et al, 2000; Wagener et al, 2001) . The products of the heme degradation by heme oxygenase, CO, and bilirubin, have cyto-protecting properties against oxidative stress (Otterbein and Choi, 2000) . It may be speculated that t-a 1 m, which seems to have its hemedegrading property in common with heme oxygenase (Allhorn et al, 2002) , a¡ects heme in a similar way giving rise to these antioxidative mediators.
Another product of heme degradation is, of course, free iron. The results in this paper, in agreement with previous reports, demonstrate the presence of iron in the ulcer £uids, as well as iron deposits in chronic wound sections. Interestingly, the levels of iron (free þ protein bound) were lower in wound £uids and plasma from chronic ulcer patients than in normal plasma, whereas iron deposits were seen in chronic wound tissue but not in acute wound or normal tissue. This suggests that the iron-chelating mechanisms are insu⁄cient in the in£ammatory tissue. Iron represents an oxidative threat to the tissue components, but heme oxygenase has been suggested to promote sequestering of the iron into the storage protein ferritin, which serves a dual role by hiding the iron and itself possesses a cyto-protective and anti-oxidant activity (Balla et al, 1992; Otterbein and Choi, 2000; Ryter and Tyrell, 2000) . It may be speculated that a 1 m has a similar effect as heme oxygenase also in this case, promoting iron storage; however, additional observations are necessary before any conclusions can be drawn about the role of a 1 m in iron metabolism.
Unlike heme oxygenase, a 1 m operates extracellularly, possibly providing the main source of protection against unsequestered heme in the extracellular space. In conclusion, our results support the concept of a 1 m as part of a novel endogenous defense mechanism against heme-induced oxidative stress.
